Cargando…
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
Peripheral decarboxylase inhibitors (PDIs) prevent conversion of levodopa to dopamine in the blood by the enzyme aromatic L-amino acid decarboxylase (AADC). Alterations in enzyme activity may contribute to the required higher dosages of levodopa observed in many patients with Parkinson’s disease. We...
Autores principales: | van Rumund, Anouke, Pavelka, Lukas, Esselink, Rianne A. J., Geurtz, Ben P. M., Wevers, Ron A., Mollenhauer, Brit, Krüger, Rejko, Bloem, Bastiaan R., Verbeek, Marcel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979935/ https://www.ncbi.nlm.nih.gov/pubmed/33741988 http://dx.doi.org/10.1038/s41531-021-00172-z |
Ejemplares similares
-
α‐Synuclein real‐time quaking‐induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2019) -
Factors associated with mortality in early stages of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2022) -
Human aromatic amino acid decarboxylase is an asymmetric and flexible enzyme: Implication in aromatic amino acid decarboxylase deficiency
por: Bisello, Giovanni, et al.
Publicado: (2023) -
Parkinson’s Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2018) -
Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)